Jenny Kim, M.D.

Bio

Dr. Jenny Kim is a senior pediatric hematologist-oncologist at Rady Children's Hospital-San Diego and a clinical professor of pediatrics at UC San Diego School of Medicine. She is board certified in pediatric hematology-oncology.

She earned her medical degree at Dartmouth Medical School and completed her pediatric residency at Children's Hospital of Pittsburgh. She continued training with her pediatric hematology-oncology fellowship at The Children's Hospital of Philadelphia. She has worked at Rady Children's Hospital since 2002.

Dr. Kim's clinical interests include sickle cell disease, thalassemia, other hemoglobinopathies, benign hematology, bone marrow failure syndromes and histiocytic diseases. She is the medical director of the Comprehensive Sickle Cell Program at Rady Children's. She is involved with clinical trials for sickle cell disease, platelet disorders and clotting disorders. Dr. Kim is a Medical Informatics Champion and Health Information Medical Advisory Committee member for the hematology-oncology division. She also remains very involved in teaching hematology-oncology fellows, pediatric residents and medical students.

Outside of work, she enjoys spending time with her family and cheering on her kids at their field hockey and softball games. An avid baseball and hockey fan, she is often seen sporting San Diego Padres or Pittsburgh Penguins jerseys.

Publications

Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.
Parekh D, Lin H, Batajoo A, Peckham-Gregory E, Karri V, Stanton W, Scull B, Fleishmann R, El-Mallawany N, Eckstein OS, Prudowsky ZD, Gulati N, Agrusa JE, Ahmed AZ, Chu R, Dietz MS, Goldman SC, Hogarty MD, Imran H, Intzes S, Kim JM, Kopp LM, Levy CF, Neff P, Pillai PM, Sisk BA, Schiff DE, Trobaugh-Lotrario AD, Walkovich K, McClain KL, Allen CE

Severe medication-induced peripheral neuropathy treated with topical doxepin cream in a paediatric patient with leukaemia.
Dworsky ZD, Bennett R, Kim JM, Kuo DJ

Refined multivalent display of bacterial spore-binding peptides.
Lusvarghi S, Kim JM, Creeger Y, Armitage BA

Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.
Brown VI, Fang J, Alcorn K, Barr R, Kim JM, Wasserman R, Grupp SA

Role of the BCR complex in B cell development, activation, and leukemic transformation.
Rheingold SR, Brown VI, Fang J, Kim JM, Grupp SA

Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemia.
Kim JM, Fang J, Rheingold S, Aplenc R, Wasserman R, Grupp SA

See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.

PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.